SEC 13F Intelligence

Orbimed Advisors LLC / CMPX

Orbimed Advisors LLC’s Compass Therapeutics Inc Position

Does Orbimed Advisors LLC own Compass Therapeutics Inc (CMPX)? Yes — 15.22M shares worth $81M (+1.60% of its 13F portfolio) as of Q1 2026.

Position Value
$81M
Q1 2026
Shares
15.22M
% of Portfolio
+1.60%
Quarters Held
18
currently held

Position History CMPX

Reported value by quarter
Q4 ’21: $69MQ4 ’21Q1 ’22: $30MQ2 ’22: $58MQ3 ’22: $50MQ3 ’22Q4 ’22: $112MQ1 ’23: $73MQ2 ’23: $71MQ2 ’23Q3 ’23: $44MQ4 ’23: $35MQ1 ’24: $44MQ1 ’24Q2 ’24: $22MQ3 ’24: $41MQ4 ’24: $32MQ4 ’24Q1 ’25: $42MQ2 ’25: $40MQ3 ’25: $53MQ3 ’25Q4 ’25: $82MQ1 ’26: $81Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202615.22M$81M+1.60%
Q4 202515.22M$82M+1.67%
Q3 202515.22M$53M+1.25%
Q2 202515.22M$40M+0.99%
Q1 202522.36M$42M+1.01%
Q4 202422.36M$32M+0.67%
Q3 202422.36M$41M+0.75%
Q2 202422.36M$22M+0.44%
Q1 202422.36M$44M+0.81%
Q4 202322.36M$35M+0.70%
Q3 202322.36M$44M+0.94%
Q2 202322.36M$71M+1.29%
Q1 202322.36M$73M+1.44%
Q4 202222.36M$112M+2.15%
Q3 202221.96M$50M+0.93%
Q2 202221.96M$58M+1.05%
Q1 202221.64M$30M+0.48%
Q4 202121.64M$69M+0.88%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Orbimed Advisors LLC’s full portfolio or all institutional holders of CMPX.